Tag Archives: EXCLUSIVE

Exclusive: Lilly hit by staff accusations, FDA scrutiny at COVID drug factories

Exclusive: Lilly hit by staff accusations, FDA scrutiny at COVID drug factories© Reuters. FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar

By Dan Levine and Marisa Taylor

(Reuters) – Eli Lilly & Co (NYSE:) employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the U.S. plant producing the drugmaker’s COVID-19 treatment, according to an internal Lilly complaint and a source familiar with the matter.

The unsigned report, filed April 8 in Lilly’s confidential employee complaint system and reviewed by Reuters, is the latest sign of manufacturing problems at the drug giant. The complaint asserts that the executive, a top quality official at the company’s factory in Branchburg, New Jersey, rewrote findings by Lilly technical experts at the plant, which has been under investigation by the U.S. Food and Drug Administration, to make the conclusions appear more favorable to the company.

The source, who spoke on condition of anonymity, said the findings involved the production of drugs including Lilly’s COVID-19 therapy, whose use in the United States is funded by the federal government. The coronavirus antibody treatment, bamlanivimab, has been authorized by the FDA for emergency use in combination with a second Lilly drug for mild to moderate infections in people at high risk of severe illness.

Separately, FDA inspectors in March identified numerous manufacturing lapses at a second Lilly facility in Indianapolis that bottles the COVID-19 therapy and other drugs. The problems included substandard sanitation and quality control procedures, according to a preliminary FDA inspection report released to Reuters under open records laws. The Indianapolis inspection findings have not been previously reported.

The troubles at the two factories, along with a succession of internal complaints in recent years, deepen the regulatory, production and leadership issues facing Lilly, one of the largest drugmakers in the world. In addition to the FDA investigations, Lilly’s chief financial officer resigned in February over what the company called “inappropriate personal communications” with an employee. He has declined to comment in the past and could not be reached Tuesday.

As Reuters reported in March https://www.reuters.com/article/us-health-elililly-special-report/special-report-insider-alleges-eli-lilly-blocked-her-efforts-to-sound-alarms-about-u-s-drug-factory-idUSKBN2B31K5, a human resources officer at the Branchburg factory said she was forced out of her job after raising concerns about quality control, record-keeping and staff shortages in the Branchburg factory. The company has denied any retaliation against employees.

Contacted by Reuters for this story, Lilly confirmed it had received the recent employee complaint about the Branchburg plant. The company said it could not comment further given that an investigation was underway by an independent third party, which it did not identify.

“Depending on the outcome of that investigation, we will take appropriate action,” said Lilly spokeswoman Kathryn Beiser. “Lilly has long-standing policies and procedures designed to enable – and encourage – individuals to come forward with information about any potential issues or concerns without fear of retribution.”

Lilly also confirmed that it had submitted a response to the FDA about its recent inspection of the Indianapolis plant. The company declined to share the document with Reuters, and said none of the issues identified by the FDA at either plant has affected the quality of products released in the marketplace.

Amid the escalating manufacturing problems, however, the Branchburg plant has not shipped new batches of the COVID-19 drug bamlanivimab in nearly two months, according to the employee complaint and the source familiar with the matter. Reuters could not independently confirm that the Branchburg plant was not releasing bamlanivimab to the Indianapolis bottling plant or other facilities.

Lilly did not respond to questions about whether shipments have stalled at Branchburg, though the company said it expected to meet its production commitments for the COVID-19 treatment.

The Branchburg factory executive named in the complaint, Lydia Wible, did not respond to requests for comment made via email and telephone. On her behalf, Lilly said she declined to comment.

Lilly did not make Chief Executive Officer David Ricks available for comment. Reuters found no evidence he knew of the problems described in the complaint.

The new complaint about the Branchburg facility refers to “13 employees involved in this investigation.” It does not identify them, saying they fear retaliation. The source familiar with the matter said the group that submitted the complaint comprises more than 10 employees, including managers.

The source claimed that many of the staffers had seen the relevant documents both before and after they were altered.

The complaint did not specify what alterations the employees believed were made to the documents but said Wible “rewrites factual data provided by subject matter experts to formulate responses she feels are more beneficial.”

It is not clear whether any of the documents have been submitted to the FDA, although the agency routinely reviews such records.

The FDA declined to answer questions on the Lilly inspections or the employee complaint, but said “the agency takes the safety and quality of FDA-regulated products seriously” and noted that it imposed quality control measures when it authorized bamlanivimab.

The U.S. Department of Health and Human Services, which oversees vaccine and therapeutics production, did not respond to requests for comment.

Nathan Cortez, a law professor who specializes in FDA regulation at Southern Methodist University in Texas, said the employee accusations regarding Branchburg and Indianapolis could amplify Lilly’s problems with regulators.

“If you have a string of manufacturing problems across multiple facilities and you’re starting to develop a not-so-great manufacturing track record, the FDA will probably consider harder responses,” he said. Referring to the internal complaint, he said: “If somebody is sticking their neck out, that strikes me as a pretty big deal and evidence of some deeper problems within the company.”


The April complaint asserts that Wible, the Branchburg factory executive, altered information provided by internal technical experts, saying she is “solely responsible for providing written responses to the FDA” regarding the types of quality control problems that regulators flagged.

The complaint said that Wible – who did not respond to questions from Reuters – used “her authority to rewrite technical investigations for which she has little or no experience.”

According to the complaint, staff members who gather information for the FDA were concerned about presenting altered material to regulators. They “are uncomfortable and do not feel confident in defending the reformulated responses in the event they are called upon by the FDA,” the complaint said.

The complaint also expressed impatience with company leaders.

“How long is it going to take for the company to pay attention and do something about this?” it said, referring to the accusations against Wible. “We are all working very hard to meet the commitments to the FDA and cannot do so under these conditions.”

The complaint said Wible had, prior to recently altering the records required by the FDA, provided “fabricated” information including “fictitious numbers” to a Branchburg human resources investigator looking into potential manufacturing lapses.

Asked by Reuters about the matter, former human resources investigator Amrit Mula confirmed that she had concluded through an internal inquiry in 2018 that Wible had given her fabricated information. Mula said she was looking into unsanitary conditions in a warehouse, as well as information about the improper disposal of quality-control records for Trulicity, a blockbuster diabetes drug then made at the plant.

Reuters reported in March that Mula claimed to have identified serious violations of FDA manufacturing rules at the plant and to have been forced out of the company in early 2019. Mula has since sought compensation from Lilly, arguing the company retaliated against her for raising legitimate concerns as part of her job.

Senior executives at Lilly headquarters in Indianapolis, including Leanne Hickman, vice president of quality, knew about the alleged fabrications and retaliation and protected Wible, doing nothing to address the problems, according to the complaint.

Hickman did not respond to requests for comment conveyed by email and telephone. On her behalf, Lilly said she declined to comment.

In November 2019, roughly eight months after Mula’s departure, FDA inspectors showed up at the Branchburg plant for a routine inspection and cited some of the same problems Mula said she had repeatedly flagged to her bosses. The preliminary FDA report found that quality control data on various manufacturing processes had been deleted and not appropriately audited.

The FDA red-flagged the problems as “Official Action Indicated,” or OAI, which is its most serious category of violation. If not addressed, an OAI can lead to a prohibition on the sale of drugs from a facility, regulatory experts say. The FDA has not taken further public action.

Inspectors returned in July and found several more problems, including that the company failed to properly investigate quality-control problems to prevent recurrence and that batches of drugs had been discarded because of manufacturing mistakes.

In October, the Trump administration ordered $ 375 million worth of bamlanivimab and shortly afterward authorized its use on an emergency basis to help curb the pandemic. Bamlanivimab is combined with a second Lilly drug, called etesevimab, to treat COVID-19.


A condition of the emergency authorization was that an outside auditor inspect batches of bamlanivimab to ensure they met FDA standards. Lilly and the FDA have not responded to questions from Reuters about whether this requirement was carried out.

Lilly said in March that its combination antibody therapy reduced the risk of hospitalization and death by 87% in a study of more than 750 high-risk COVID-19 patients.

Around he same time, the FDA inspected the Indianapolis plant, which receives the kinds of injectable drugs manufactured in New Jersey, fills them into vials and syringes, and distributes them to customers.

Preliminary FDA reports, which are partially redacted, show inspectors found that procedures to ensure certain areas remain sterile were substandard and that Lilly failed to thoroughly investigate drug batches that had failed quality control tests. In addition, when vials from outside vendors were discarded as defective, the company failed to thoroughly investigate.

“The FDA found serious concerns on multiple fronts,” said Steven Lynn, a former head of the FDA’s Office of Manufacturing and Product Quality, who reviewed the inspection report for Reuters. “Lilly has a lot of work to do.”

(Dan Levine reported from San Francisco and Marisa Taylor from Washington, D.C. Editing by Michele Gershberg and Julie Marquis)

Author: Reuters
This post originally appeared on Stock Market News

Andrew Pozzi getting 'creative' in challenging preparations for Tokyo Olympics – EXCLUSIVE

Every athlete has a special bond with their coaching team, built from years of dedication on the track and in the gym working a four-year cycle in preparation for the biggest sporting event in the world. The coronavirus pandemic though has challenged most athletes to find a way to adapt their training schedule and Britain’s Andrew Pozzi has had it tougher than most.
Pozzi made the decision a few years ago to join up with legendary Cuban coach Santiago Antunez – who worked with two Olympic 110m hurdles champions in Dayron Robles back in 2008 and Anier Garcia in 2000 – at his training base in Italy.

The big change from training in Loughborough to the Italian Olympic Association high-performance base in Formio has helped shape Pozzi into becoming a big medal hopeful at the Tokyo Olympics.

Those hopes and dreams came to a sudden halt last year when news broke that the COVID-19 pandemic would cause the Olympic Games to be postponed for another year.

Athletic meets would slowly get back up and running on a limited schedule and there was a bittersweet moment when Pozzi matched his 13.14-second outdoors personal best over the 110m hurdles in Monaco in August – one week after the hurdles final for the 2020 Olympics would have taken place.

Athletes have faced restrictions on who they’re allowed to bring with them to events and that has affected Pozzi more than most.

At 73 years of age, Antunez is at higher risk of catching the coronavirus but the iconic hurdles coach had his first dose of the vaccine in March with the second coming in May – when the outdoor season gets started.

JUST IN: Fourth Covid wave strikes Japan sparking fears for 2021 Olympics

It’s meant that Pozzi has had to get used to a “solitary” lifestyle in recent months without his coach being at his side but Antunez’s vaccination means things could soon return to normal with the Tokyo Olympics less than 100 days away.

“That’s a huge weight off our minds because it means for most of the outdoor season he’ll be able to travel, certainly by the Olympics he’ll be there,” Pozzi told Express Sport.

“We’ve done a good job of working around that and I think there’s been a great spirit among different athletes because even at the competitions there’s been far fewer coaches allowed to try and keep the numbers down.


“From that point of view, everybody’s helped each other and if there has been one coach then they’ve helped several athletes so there’s been a nice camaraderie that’s come out of having to adapt to competitions in the covid world these days.

“Pozzi’s preparations for the start of 2021 were also hampered by a hamstring injury which meant he was only able to begin training a few weeks before the European Indoor Championships.

Despite the setback, and challenges of training without his coach by his side, Pozzi was able to clinch silver over the 60m hurdles in another equal personal best.

Pozzi’s disappointment in not winning gold was quickly overtaken by the belief that if his time in Torun, Poland was achievable having just recovered from an injury then he should be on track to make even bigger strides by the time he travels to Tokyo.

“It’s a frustrating one because you always want to win,” he added.

“In hindsight and when you have a chance to reflect, it was a good performance because it was an equal PB and I lost two months training from December and I only started again around three weeks before the champs because I had a bit of an injury.

“It’s probably a little quicker than I thought I was able to do. Training before that was going so well, I was really excited but we had to really work hard to adapt because I wasn’t able to train the way I liked for about six weeks.

“So from that point of view, to run an equal PB, means that I’m really on a great track for the outdoors and I’ve just looked at it like that.

“At this stage I’m a little more relaxed. Now in Italy, I’m allowed to train almost completely normally.

“From that point of view, we’ll have lots of time to prepare so I think we’re on track to do really well in the summer.

“I wouldn’t have chosen for it to happen but at the same time it’s actually been a really positive learning experience for me.”

His ideal preparations are still up in the air though with new post-Brexit rules limiting British citizens to a stay of 90 days in the European Union during any 180-day period, but Pozzi is hopeful the need for a change in regulation will spark the right kind of “conversations”.

“I think we can see a relatively clear route to me getting back but the longer time goes on, the easier that will become because it’s recognised as a problem,” Pozzi added.

“At the moment, because of the coronavirus, there aren’t lots of people trying to do it.

“There aren’t lots of sports competitions, music festivals for people to be travelling around so I think it’s been somewhat overlooked whereas now the conversation is kind of starting.”

Pozzi is planning to return to the UK in July anyway for the Muller Anniversary Games (July 13), for what will be his last competitive meeting before travelling to Tokyo and he’s hopeful of seeing fans in the stadium.

“That will be the last competition before the Olympics and that’s going to be perfect because it’s going to be a huge meeting,” Pozzi said.

“Undoubtedly you’re going to get the best athletes in the world wanting to come over to London to race there in order to get their preparations sorted so fingers crossed we’re able to get some fans in the stands.”

Andrew Pozzi is a Müller Ambassador and member of the Müller Athletic Squad. Müller are the official yogurt of British Athletics and Athletics Ireland. The Müller Anniversary Games will be held at the London stadium on the 13th July

This post originally appeared on Daily Express :: Sport Feed

Long lost franchise heading to PS5 as an exclusive? Xbox Series X fans would be jealous

The ninth-console generation is unlike any other, with all platform holders truly offering something different. While Nintendo has long gone on its own ever since the GameCube era, trying something different with the Wii onwards Sony and Xbox have largely been in a battle of horsepower and who has the best AAA exclusives. This time around it’s different though, with Sony going down a traditional console route with the PS5 and Microsoft pushing the value of its Game Pass service with the Xbox Series X and S.
At the start of this gen Sony has already bolstered its incredible first-party exclusive line-up with third-party exclusives, such as upcoming games Forsaken and Final Fantasy 16 from Square Enix and Deathloop and GhostWire: Tokyo from Bethesda.

And Sony may have another third-party exclusive up its sleeves that Xbox gamers may be jealous about.

Twitter user and YouTuber @foxygames_uk is hinting at an unannounced PS5 timed exclusive.

And while the gaming tipster did not specifically name what IP Sony might have struck a deal for a heavy hint was dropped.

Foxy Games UK tweeted: “Hong Kong seems like a really good setting for a unannounced #PS5 *Timed Exclusive.”

Looking back, there aren’t too many Hong Kong-based games that could be getting revived for the PS5.

The PS3 and Xbox 360 got the John Woo shooter Stranglehold, but given how niche that title was a follow-up seems unlikely.

The more obvious candidate, however, would be another long lost franchise from the PS3 and Xbox 360 era.

Sleeping Dogs is a Hong Kong-based open-world crime game in the vein of GTA.

It was originally envisioned as part of the True Crime series, before that series was canned.

Sleeping Dogs received positive reviews on its release in 2012, getting an 83 PS3 Metacritic rating and an 80 Xbox 360 Metacritic score.

While the open-world crime game also debuted in at number one on UK games sales charts, going on to sell 1.5million copies within its first month and a half on sale.

But despite the new IP winning over plenty of fans, a sequel to the title ended up getting scrapped and news on the franchise has gone quiet.

An enhanced version was released for the PS4 and Xbox One in 2014, with a macOS edition also dropping in 2016.

But apart from that news on whether the franchise will continue has gone quiet.

The tweet from Foxy Games UK, however, has sparked speculation that the franchise could be about to make a return.

Replying to the tweet one gamer posted: “Sleeping Dogs would be amazing”.

While another wrote: “Sleeping Dogs?”

And one added: “Stop tempting us”.

With a Sleeping Dogs movie in the works starring Ip Man martial arts legend Donnie Yen now could be the perfect time to revive the series.

Square Enix will be taking part in E3 this year, so if a Sleeping Dogs revival is in the works we may find out then.

This post originally appeared on Daily Express :: Gaming Feed

Faraday Future signs Velodyne as exclusive lidar supplier for luxury EV

Author: Reuters
This post originally appeared on Stock Market News

Faraday Future signs Velodyne as exclusive lidar supplier for luxury EV© Reuters. Faraday Future’s luxury electric car FF91 is seen at the company’s headquarters in Gardena

(Reuters) – Faraday Future has selected Velodyne Lidar Inc as an exclusive supplier for its flagship luxury electric car FF 91, which is due to be launched next year, the sensor maker said on Thursday.

Lidar, which stands for light detection and ranging, is a remote sensing system that generates a three-dimensional map of the road ahead for vehicles and also helps with applications such as augmented reality in smart devices.

San Jose, California-based Velodyne, an early entrant into the lidar market, said Faraday’s FF 91 cars would use the Velarray H800 lidar sensors to power their autonomous driving system.

The deal comes days after the sensor maker signed a multi-year sales agreement with Silicon Valley self-driving startup Gatik, to use its lidar technology in on-road transportation networks.

Faraday Future, which agreed to be taken public by the blank-check firm Property Solutions Acquisition Corp in January, initially planned to launch its FF 91 car in 2019. However, it faced multiple production delays owing to financing issues.

The Los Angeles-based electric vehicle maker now plans to launch the FF 91 within 12 months of closing its merger with Property Solutions.

X: Therefore doesn`t .

‘They are exclusive’: NBA star Devin Booker ‘holds hands’ with model and ‘Keeping up with the Kardashians’ stunner Kendall Jenner

Author: RT
This post originally appeared on RT Sport News

Two-time NBA All-Star Devin Booker has reportedly taken his relationship with US it-girl Kendall Jenner a step further over the weekend, sending gossip columns wild after he was pictued holding her hand in New York.

Towering shooting guard Booker has been linked with Jenner since the pair took a road trip from Los Angeles to Arizona together last April, although celebrity outlets in the US widely reported that they had kept their partnership low-key and casual.

The 24-year-old Phoenix Suns superstar has not featured TV favorite Jenner in any of his Instagram photos, preferring to use the more temporary Stories feature on the platform to show them lying on a blanket in a picturesque outdoor setting.

Jenner, who is the half-sister of mega-famous celebrities Kim, Khloe, Kourtney and Rob Kardashian, is said to be more content with Booker than she had been in her previous two reported relationships with NBA players, dating Blake Griffin and Ben Simmons for less than a year each.

“This is the happiest Kendall has ever been in a relationship,” People quoted a source as saying about the 25-year-old socialite. “She and Devin started out slowly but have dated for about a year now.

“What first seemed like a fun hookup is now a relationship. They are exclusive and Kendall is very happy with Devin.

“Her family thinks he is great. He was even invited to Kim’s 40th birthday celebration in Tahiti.”

Booker could not resist leaving a comment on Jenner’s Instagram, where she is followed by a staggering fanbase of more than 160 million, after she pictured herself in a floral dress in woodland earlier this month, writing: “Very beautiful… course.”

On Valentine’s Day, Jenner pictured herself lying on what appeared to be a kitchen worktop underneath Booker, adding a white heart symbol as the pair laughed together.

The son of former professional basketball player Melvin, 6ft 5in Booker has been named on the All-Star team in each of the past two seasons.

He was supported by NBA legend LeBron James earlier this year, who told his millions of social media followers: “Devin Booker is the most disrespected player in our league – simple as that.”

Jenner was heavily criticized in November after reportedly throwing a huge maskless party at the height of the Covid-19 pandemic, attended by a plethora of celebrities including pop star Justin Bieber and actor Will Smith’s son, Jaden.

“All we can do is live our lives the best way we know how and be responsible and do the right thing, and we’re doing that exactly,” she told a radio show as a backlash ensued, adding that her family was “very lucky to work in an industry where we get tested once or twice a week.”

Also on rt.com Tennis golden couple Elina Svitolina & Gael Monfils announce their engagement – just a month after they ‘decided to take a break’

Presented by


Exclusive: Online bookmaker Betway parent nears $5.1 billion deal to go public -sources

Author: Reuters
This post originally appeared on Stock Market News

2/2 Exclusive: Online bookmaker Betway parent nears $  5.1 billion deal to go public -sources© Reuters. Milwaukee Bucks training ahead of the NBA Paris Game 2020 2/2

By Joshua Franklin and Anirban Sen

(Reuters) – Super Group, the parent company of online bookmaker Betway, is nearing a deal to go public through a merger with blank-check acquisition firm Sports Entertainment Acquisition Corp at a valuation of about $ 5.1 billion, people familiar with the matter said on Saturday.

The deal comes as Betway, which has its roots in Europe, expands in the United States. Betway has agreed to acquire Digital Gaming Corp, tapping the online sports betting and gaming market in 10 U.S. states, according to the sources.

Shareholders accounting for more than two-thirds of Super Group’s equity will maintain their stakes under the deal, the sources said. Sports Entertainment’s executive chairman, Eric Grubman, a former National Football League (NFL) executive, will become chairman of Super Group, and Sports Entertainment CEO John Collins, a former National Hockey League chief operating officer, will join Super Group’s board, the sources added.

The sources requested anonymity because the deal negotiations are confidential.

SPACs, such as Sports Entertainment, are shell companies that raise funds in an initial public offering with the aim of merging with a private company, which becomes public as result, providing an alternative to traditional IPOs.

SPAC dealmaking tailed off in recent weeks following a record start to 2021 after U.S. regulators changed the accounting requirements for them.

Betway’s platform enables betting on popular sporting events around the world, including Britain’s Premier League football tournament and the cricket tournament Indian Premier League. It has partnerships with U.S. basketball teams such as the Chicago Bulls, Golden State Warriors, Brooklyn Nets and Los Angeles Clippers, and English football teams such as West Ham United.

Betway earlier this year entered the U.S. betting market, which has been growing rapidly since a ban on sports betting was lifted in 2018.

Super Group also owns Spin, a multi-brand online casino offering. It counts the likes of former cricketer Kevin Pietersen and former jockey Katie Walsh among its ambassadors.

Sports Entertainment Acquisition completed its IPO in New York in October, raising $ 400 million. It is backed by Timothy Goodell, general counsel of U.S. oil producer Hess Corp (NYSE:) and brother of NFL commissioner Roger Goodell, and an affiliate of investment bank PJT Partners (NYSE:) Inc.

X: Therefore doesn`t .

Man Utd chief John Murtough safe at Old Trafford after Ed Woodward exit – EXCLUSIVE

This post originally appeared on Daily Express :: Sport Feed

Yet Express Sport understands that isn’t the case and that he’ll instead be staying at Old Trafford, poised to play a vital role in future ongoings at the club.

His biggest responsibility is helping United across all levels, and with recruitment in particular.

Signings have been mixed, to say the least, since Woodward rocked up as David Gill’s successor back in the summer of 2013.

There have been hits, ranging from Bruno Fernandes to Harry Maguire, Luke Shaw to Zlatan Ibrahimovic.

But there have also been too many misses for the club’s liking, with the likes of Alexis Sanchez, Angel Di Maria, Radamel Falcao, Morgan Schneiderlin, Memphis Depay and Bastian Schweinsteiger all flopping.

United have several transfer targets in mind for the summer.

Erling Haaland is their main goal, with the Borussia Dortmund striker seen as a potential replacement for Cavani.

David Haye has Anthony Joshua theory ahead of blockbuster Tyson Fury fight – EXCLUSIVE

This post originally appeared on Daily Express :: Sport Feed

The whole boxing world will be tuning in when Anthony Joshua and Tyson Fury lace it up and step into the ring for their undisputed heavyweight bout and David Haye believes the former has already been written off as the underdog. Contracts have been signed on a two-fight deal with Saudi Arabia set to host the first bout in late July.
It’s expected to be the biggest heavyweight fight in history with the winner to become the first unified champion in the four-belt era.

Fury and Joshua are in the primes of their career as well at 32 and 31 years of age respectively.

The latter heads into this summer’s contest with more recent experience having knocked out Kubrat Pulev back in December, while Fury hasn’t fought since his resounding victory over Deontay Wilder at the start of 2020.

Haye believes Fury is still riding the wave of that impressive win to clinch the WBC heavyweight belt.

And the former unified cruiserweight world champion believes that has had a knock-on effect to the public’s view on Joshua.

JUST IN: Anthony Joshua and Tyson Fury agree on fight site for mega-fight

“A lot of people are making Tyson Fury the favourite after his amazing performance against Deontay Wilder in Las Vegas,” he told Express Sport.

“A fight I thought was one of the best heavyweight contests I’ve ever seen. I didn’t know that Tyson Fury could fight the way he did and I think he shocked Deontay Wilder.

“I rate Deontay Wilder – I still do – but he [Fury] made him look very, very ordinary.

“He made him look even more ordinary than his previous fights that weren’t that good and those guys went the distance.


“So for him to go out there and dominate shows that he’s got a lot in his locker, but I think that fight has stopped people believing in Anthony Joshua.

“Off the strength of that amazing victory, they’ve written off Anthony Joshua and write him off at your peril.”

Haye goes on to suggest that Fury may well be caught out if he underestimates Joshua.

“Anthony Joshua has been working very hard behind the scenes whilst Tyson Fury has been celebrating his amazing victory. A lot of people see him [Fury] as the world No 1 as he’s just beaten the WBC champion,” Haye added.

“Fury, I don’t believe he believes he has to raise anything. I think he just thinks he’s better.

“He just thinks he turns up and he’s just going to beat up Anthony Joshua and I don’t believe that’s the case.

“I just think it’s the perfect time for Anthony Joshua. Everyone is writing him off. He’s going to be an underdog but even being the underdog I think will help him.

“It didn’t help him how everyone was saying how easy the fight with Ruiz was going to be. I think that worked against him.

“This time everybody is going to doubt him. He’s got nothing to lose. He’s going to go out there with not many people believing he’s going to win.

“He’s going to go out there and prove everybody wrong and he’s going to show the world what he’s all about.

“Experts have written him off… but he’s a very special boxer and someone who I don’t believe has shown everything that he’s got.

“I believe there’s so much more in the locker, he’s proven as a fighter and he’s got better every time I’ve seen him and I just believe it’s the perfect time for him to show what he’s really got.”

Haye also helped launch The Black Mask Company last year with sports stars such as Lewis Hamilton wearing them and the former British boxing superstar opened up on the background to his business venture.

“A buddy of mine lives in Vietnam and they did a lockdown in January last year so way ahead of pandemic,” he added.

“90 per cent of Vietnamese where washable face masks and it’s crept into their culture over the years and I worked out through my Vietnamese contacts that the government had issued the commission of a three-layer washable face mask and I though hook or by crook managed to get the worldwide distribution of this mask.

“They don’t make many of them but the ones they do make, I’m able to bring to the UK and sell. They’re super comfortable and more importantly they’re biodegradable.

“There’s 129million masks per month getting dropped into landfills and washing up in our oceans and it’s become a massive issue so this washable mask, it’s something where I’ve always been a big advocate for sustainability.”

The Black Mask Company, founded by David Haye, launches rainbow mask to thank our NHS heroes, get yours at www.theblackmaskcompany.com/products/rainbow-mask

Sky, NOW TV and Roku users just got more exclusive content to watch for FREE

This post originally appeared on Daily Express :: Tech Feed

“Every day, millions of viewers turn to The Roku Channel to find quality programming they love,” said Sweta Patel, Vice President of Engagement Growth Marketing, at Roku.

“We’re thrilled to introduce this award-winning and diverse portfolio of entertainment under the Roku Originals brand – it’s relevant, fun and thought-provoking TV that has something for everyone from the best talent in Hollywood, including Anna Kendrick, Chrissy Teigen, Lena Waithe, Idris Elba, Kevin Hart, and Liam Hemsworth. The Roku Channel is the place for incredible, free programming and we are excited to bring this premium content to the biggest screen in the home.”

The Roku Originals will join The Roku Channel’s current lineup of more than 25,000 free movies and programs which include shows such as MasterChef, Jerry Springer, The Simple Life and Mythbusters.

Tottenham eye Nuno Espirito Santo as Jose Mourinho replacement – EXCLUSIVE

Chairman Daniel Levy is a major fan of the charismatic Wolves manager, who led the club out of the Championship three years ago and has taken them to the Europa League quarter-finals and two seventh-placed Premier League finishes.
Nuno signed a new deal at Wolves in September tying him to the club until 2023 – but has been linked with a move to Arsenal.

The former Valencia and Porto coach, now 47, has seen his team dip in form this season as injuries have struck, but are currently lying twelfth in the Premier league table, safe from any relegation fears.

Mourinho is under mounting pressure at Tottenham, after Sunday’s 3-1 defeat by Manchester United left them lying six points outside the Champions League places – and three away from the Europa League qualification slots.

Spurs can still get into Europe if they lift the Carabao Cup by beating Manchester City at Wembley on Sunday week, but even then they would only be in the Uefa Europa Conference League – not regarded as a top-level competition.

But Mourinho could register his club’s first trophy since 2008.

Spurs have seven league games left – and qualification for Europe’s major competitions will have a major bearing on whether Levy decides to stick with Mourinho.

Wolves’ season has been badly hit by injuries, with top scorer Raul Jimenez’ fractured skull in November a huge blow to Nuno’s plans.

There were reports in January that a frustrated Nuno had instructed his agent Jorge Mendes – also Mourinho’s agent – to look for another club.

Mourinho’s contract still has two years to run and it would cost Spurs a considerable amount in compensation to sack the Portuguese – but that figure would reportedly drop if they fail to qualify for Europe.

Nuno also has two years left on his deal – and the compensation to Wolves would cost around £8 million.

Spurs have also been linked with Leicester manager Brendan Rodgers and former Chelsea boss Maurizio Sarri.

This article originally appeared on Daily Express :: Sport Feed